Page last updated: 2024-10-17

phosphonoacetic acid and Stomatitis

phosphonoacetic acid has been researched along with Stomatitis in 5 studies

Phosphonoacetic Acid: A simple organophosphorus compound that inhibits DNA polymerase, especially in viruses and is used as an antiviral agent.
phosphonoacetic acid : A member of the class of phosphonic acids that is phosphonic acid in which the hydrogen attached to the phosphorous is replaced by a carboxymethyl group.

Stomatitis: INFLAMMATION of the soft tissues of the MOUTH, such as MUCOSA; PALATE; GINGIVA; and LIP.

Research Excerpts

ExcerptRelevanceReference
"In a previous trial in which methotrexate and N-phosphonacetyl-L-aspartate (PALA) were used to modulate 5-fluorouracil (5-FU), four of six patients could not tolerate treatment at the 600 mg/m2 5-FU dose level because of mucositis, diarrhea, and a decrease in performance status."3.68Uridine allows dose escalation of 5-fluorouracil when given with N-phosphonacetyl-L-aspartate, methotrexate, and leucovorin. ( Colofiore, J; Kemeny, N; Martin, D; Sawyer, R; Schneider, A; Seiter, K; Williams, L, 1993)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19904 (80.00)18.7374
1990's1 (20.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
O'Connell, MJ2
Rubin, J1
Schutt, AJ1
Moertel, CG1
Kvols, LK1
Kurzrock, R1
Yap, BS1
Plager, C1
Papdopoulos, N1
Benjamin, RS1
Valdivieso, M1
Bodey, GP1
Creagan, ET1
Kovach, JS1
Seiter, K1
Kemeny, N1
Martin, D1
Schneider, A1
Williams, L1
Colofiore, J1
Sawyer, R1
Erlichman, C1
Strong, JM1
Wiernik, PH1
McAvoy, LM1
Cohen, MH1
Levine, AS1
Hubbard, SM1
Chabner, BA1

Trials

1 trial available for phosphonoacetic acid and Stomatitis

ArticleYear
Clinical trial of PALA and L-Alanosine in advanced colorectal carcinoma.
    Cancer treatment reports, 1983, Volume: 67, Issue:12

    Topics: Adult; Aged; Alanine; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Clinical Trials

1983

Other Studies

4 other studies available for phosphonoacetic acid and Stomatitis

ArticleYear
Phase II evaluation of PALA in patients with refractory metastatic sarcomas.
    American journal of clinical oncology, 1984, Volume: 7, Issue:4

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Aspartic Acid; Bone Neoplasms; Diarrhea; Drug Evaluati

1984
A Phase I study of the combination N-(phosphonacetyl)-L-aspartate (PALA, NSC-224131) and L-alanosine (NSC-153353) in patients with advanced cancer.
    Cancer, 1983, Aug-15, Volume: 52, Issue:4

    Topics: Alanine; Aspartic Acid; Diarrhea; Digestive System Neoplasms; Drug Administration Schedule; Drug Eva

1983
Uridine allows dose escalation of 5-fluorouracil when given with N-phosphonacetyl-L-aspartate, methotrexate, and leucovorin.
    Cancer, 1993, Mar-01, Volume: 71, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Diarrhea; Drug Synergism

1993
Phase I trial of N-(phosphonacetyl)-L-aspartate.
    Cancer research, 1979, Volume: 39, Issue:10

    Topics: Adolescent; Adult; Aged; Aspartic Acid; Colonic Neoplasms; Diarrhea; Drug Eruptions; Drug Evaluation

1979